Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trial

Shengli Xia, Yuntao Zhang, Yanxia Wang, +35

The Lancet Infectious Diseases

Human mobility trends during the early stage of the COVID-19 pandemic in the United States

Minha Lee, Jun Zhao, Qianqian Sun, +4

PLoS ONE

Epidemiological DynamicCovid-19 EpidemiologySocial Determinants Of HealthUnited StatesCovid-19 +21

Olfactory and Gustatory Dysfunction as an Early Identifier of COVID‐19 in Adults and Children: An International Multicenter Study

Chenghao Qiu, Chong Cui, Charlotte Hautefort, +26

Otolaryngology

Estimation of incubation period and serial interval of COVID-19: analysis of 178 cases and 131 transmission chains in Hubei province, China

Lin Yang, Jingyi Dai, Jun Zhao, +3

Epidemiology and Infection

Theoretical Study of Potential Energy Surfaces for N₁₂ Clusters

Qian Shu Li, Jun Zhao

The Journal of Physical Chemistry A

Cluster ScienceTheoretical StudyEngineeringPhysicsBiochemistry +13

Association of systemic immune-inflammation index and systemic inflammation response index with chronic kidney disease: observational study of 40,937 adults

Peixian Huang, Yanpei Mai, Jun Zhao, +2

Inflammation Research

InflammationGlomerular DiseaseGlomerulonephritisUrologyRenal Disease +9

<p>Probable Longer Incubation Period for Elderly COVID-19 Cases: Analysis of 180 Contact Tracing Data in Hubei Province, China</p>

Jingyi Dai, Lin Yang, Jun Zhao

Risk Management and Healthcare Policy

The Psychological Health Status of Healthcare Workers During the COVID-19 Outbreak: A Cross-Sectional Survey Study in Guangdong, China

Jinglong Chen, Gang Xu, Jun Zhao, +4

Frontiers in Public Health

Observed mobility behavior data reveal social distancing inertia

Sepehr Ghader, Jun Zhao, Minha Lee, +3

arXiv (Cornell University)

Individual MobilityBehavioral SciencesMobility DataU.s. StatesInertia Phenomenon +13

Upregulated IL-6 Indicates a Poor COVID-19 Prognosis: A Call for Tocilizumab and Convalescent Plasma Treatment

Jian Wu, Jiawei Shen, Ying Han, +15

Frontiers in Immunology